HDFC Pharma and Healthcare Fund Regular Plan IDCW Reinvestment vs Aditya Birla Sunlife Life Pharma and Healthcare Fund Normal Growth
NAV, returns and costs — not a recommendation.
 HDFC Pharma and Healthcare Fund Regular Plan IDCW Reinvestment |  Aditya Birla Sunlife Life Pharma and Healthcare Fund Normal Growth | |
|---|---|---|
| NAV | ₹21.613 | ₹36.3 |
| NAV date | 2026-09-29 | 2026-09-29 |
| 1 year | +28.89% | +19.53% |
| 3 year (p.a.) | +29.59% | +19.61% |
| 5 year (p.a.) | +29.59% | +13.05% |
| Expense ratio | 1.97% | 1.94% |
| Fund size | ₹2362.44 Cr | ₹1,102.73 Cr |
| Risk | — | Very high |
| Category | Sectoral Pharma and Healthcare | Sectoral Pharma and Healthcare |
Past performance does not guarantee future returns. Mutual fund investments are subject to market risks.